RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Floyd L. Wormley Jr. to Female

This is a "connection" page, showing publications Floyd L. Wormley Jr. has written about Female.
Connection Strength

0.520
  1. Leopold Wager CM, Hole CR, Wozniak KL, Olszewski MA, Wormley FL. STAT1 signaling is essential for protection against Cryptococcus neoformans infection in mice. J Immunol. 2014 Oct 15; 193(8):4060-71.
    View in: PubMed
    Score: 0.031
  2. Chaturvedi AK, Hameed RS, Wozniak KL, Hole CR, Leopold Wager CM, Weintraub ST, Lopez-Ribot JL, Wormley FL. Vaccine-mediated immune responses to experimental pulmonary Cryptococcus gattii infection in mice. PLoS One. 2014; 9(8):e104316.
    View in: PubMed
    Score: 0.031
  3. Wozniak KL, Hole CR, Yano J, Fidel PL, Wormley FL. Characterization of IL-22 and antimicrobial peptide production in mice protected against pulmonary Cryptococcus neoformans infection. Microbiology (Reading). 2014 Jul; 160(Pt 7):1440-1452.
    View in: PubMed
    Score: 0.031
  4. Chaturvedi AK, Weintraub ST, Lopez-Ribot JL, Wormley FL. Identification and characterization of Cryptococcus neoformans protein fractions that induce protective immune responses. Proteomics. 2013 Dec; 13(23-24):3429-41.
    View in: PubMed
    Score: 0.030
  5. Wozniak KL, Kolls JK, Wormley FL. Depletion of neutrophils in a protective model of pulmonary cryptococcosis results in increased IL-17A production by ?d T cells. BMC Immunol. 2012 Dec 07; 13:65.
    View in: PubMed
    Score: 0.028
  6. Hole CR, Bui H, Wormley FL, Wozniak KL. Mechanisms of dendritic cell lysosomal killing of Cryptococcus. Sci Rep. 2012; 2:739.
    View in: PubMed
    Score: 0.028
  7. Hardison SE, Herrera G, Young ML, Hole CR, Wozniak KL, Wormley FL. Protective immunity against pulmonary cryptococcosis is associated with STAT1-mediated classical macrophage activation. J Immunol. 2012 Oct 15; 189(8):4060-8.
    View in: PubMed
    Score: 0.027
  8. Wozniak KL, Young ML, Wormley FL. Protective immunity against experimental pulmonary cryptococcosis in T cell-depleted mice. Clin Vaccine Immunol. 2011 May; 18(5):717-23.
    View in: PubMed
    Score: 0.025
  9. Wozniak KL, Hardison SE, Kolls JK, Wormley FL. Role of IL-17A on resolution of pulmonary C. neoformans infection. PLoS One. 2011 Feb 17; 6(2):e17204.
    View in: PubMed
    Score: 0.025
  10. Hardison SE, Wozniak KL, Kolls JK, Wormley FL. Interleukin-17 is not required for classical macrophage activation in a pulmonary mouse model of Cryptococcus neoformans infection. Infect Immun. 2010 Dec; 78(12):5341-51.
    View in: PubMed
    Score: 0.024
  11. Hardison SE, Ravi S, Wozniak KL, Young ML, Olszewski MA, Wormley FL. Pulmonary infection with an interferon-gamma-producing Cryptococcus neoformans strain results in classical macrophage activation and protection. Am J Pathol. 2010 Feb; 176(2):774-85.
    View in: PubMed
    Score: 0.023
  12. Wozniak KL, Ravi S, Macias S, Young ML, Olszewski MA, Steele C, Wormley FL. Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis. PLoS One. 2009 Sep 03; 4(9):e6854.
    View in: PubMed
    Score: 0.022
  13. Young M, Macias S, Thomas D, Wormley FL. A proteomic-based approach for the identification of immunodominant Cryptococcus neoformans proteins. Proteomics. 2009 May; 9(9):2578-88.
    View in: PubMed
    Score: 0.022
  14. Wormley FL, Perfect JR, Steele C, Cox GM. Protection against cryptococcosis by using a murine gamma interferon-producing Cryptococcus neoformans strain. Infect Immun. 2007 Mar; 75(3):1453-62.
    View in: PubMed
    Score: 0.018
  15. Wormley FL, Heinrich G, Miller JL, Perfect JR, Cox GM. Identification and characterization of an SKN7 homologue in Cryptococcus neoformans. Infect Immun. 2005 Aug; 73(8):5022-30.
    View in: PubMed
    Score: 0.017
  16. Wormley FL, Cox GM, Perfect JR. Evaluation of host immune responses to pulmonary cryptococcosis using a temperature-sensitive C. neoformans calcineurin A mutant strain. Microb Pathog. 2005 Feb-Mar; 38(2-3):113-23.
    View in: PubMed
    Score: 0.016
  17. Wormley FL, Cutright J, Fidel PL. Multiple experimental designs to evaluate the role of T-cell-mediated immunity against experimental vaginal Candida albicans infection. Med Mycol. 2003 Oct; 41(5):401-9.
    View in: PubMed
    Score: 0.015
  18. Wozniak KL, Wormley FL, Fidel PL. Candida-specific antibodies during experimental vaginal candidiasis in mice. Infect Immun. 2002 Oct; 70(10):5790-9.
    View in: PubMed
    Score: 0.014
  19. Wormley FL, Steele C, Wozniak K, Fujihashi K, McGhee JR, Fidel PL. Resistance of T-cell receptor delta-chain-deficient mice to experimental Candida albicans vaginitis. Infect Immun. 2001 Nov; 69(11):7162-4.
    View in: PubMed
    Score: 0.013
  20. Wormley FL, Chaiban J, Fidel PL. Cell adhesion molecule and lymphocyte activation marker expression during experimental vaginal candidiasis. Infect Immun. 2001 Aug; 69(8):5072-9.
    View in: PubMed
    Score: 0.013
  21. Wormley FL, Scott M, Luo W, Baker M, Chaiban J, Fidel PL. Evidence for a unique expression of CD4 on murine vaginal CD4+ cells. Immunology. 2000 Jul; 100(3):300-8.
    View in: PubMed
    Score: 0.012
  22. Fidel PL, Luo W, Steele C, Chabain J, Baker M, Wormley F. Analysis of vaginal cell populations during experimental vaginal candidiasis. Infect Immun. 1999 Jun; 67(6):3135-40.
    View in: PubMed
    Score: 0.011
  23. Eastman AJ, He X, Qiu Y, Davis MJ, Vedula P, Lyons DM, Park YD, Hardison SE, Malachowski AN, Osterholzer JJ, Wormley FL, Williamson PR, Olszewski MA. Cryptococcal heat shock protein 70 homolog Ssa1 contributes to pulmonary expansion of Cryptococcus neoformans during the afferent phase of the immune response by promoting macrophage M2 polarization. J Immunol. 2015 Jun 15; 194(12):5999-6010.
    View in: PubMed
    Score: 0.008
  24. Rane HS, Hardison S, Botelho C, Bernardo SM, Wormley F, Lee SA. Candida albicans VPS4 contributes differentially to epithelial and mucosal pathogenesis. Virulence. 2014; 5(8):810-8.
    View in: PubMed
    Score: 0.008
  25. Feretzaki M, Hardison SE, Wormley FL, Heitman J. Cryptococcus neoformans hyperfilamentous strain is hypervirulent in a murine model of cryptococcal meningoencephalitis. PLoS One. 2014; 9(8):e104432.
    View in: PubMed
    Score: 0.008
  26. Yano J, Kolls JK, Happel KI, Wormley F, Wozniak KL, Fidel PL. The acute neutrophil response mediated by S100 alarmins during vaginal Candida infections is independent of the Th17-pathway. PLoS One. 2012; 7(9):e46311.
    View in: PubMed
    Score: 0.007
  27. Leigh JE, Steele C, Wormley F, Fidel PL. Salivary cytokine profiles in the immunocompetent individual with Candida-associated denture stomatitis. Oral Microbiol Immunol. 2002 Oct; 17(5):311-4.
    View in: PubMed
    Score: 0.003
  28. C?rdenas-Freytag L, Steele C, Wormley FL, Cheng E, Clements JD, Fidel PL. Partial protection against experimental vaginal candidiasis after mucosal vaccination with heat-killed Candida albicans and the mucosal adjuvant LT(R192G). Med Mycol. 2002 Jun; 40(3):291-9.
    View in: PubMed
    Score: 0.003
  29. Kelly KA, Gray HL, Walker JC, Rank RG, Wormley FL, Fidel PL. Chlamydia trachomatis infection does not enhance local cellular immunity against concurrent Candida vaginal infection. Infect Immun. 2001 May; 69(5):3451-4.
    View in: PubMed
    Score: 0.003
  30. Fidel PL, Wormley FL, Chaiban J, Chesson RR, Lounev V. Analysis of the CD4 protein on human vaginal T lymphocytes. Am J Reprod Immunol. 2001 Apr; 45(4):200-4.
    View in: PubMed
    Score: 0.003
  31. Leigh JE, Steele C, Wormley FL, Luo W, Clark RA, Gallaher W, Fidel PL. Th1/Th2 cytokine expression in saliva of HIV-positive and HIV-negative individuals: a pilot study in HIV-positive individuals with oropharyngeal candidiasis. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Dec 01; 19(4):373-80.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support